A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of pharmacological and toxicological methods

• Publication date

  2005-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.VASCN.2005.06.005PMID 16112590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracellular metabolites of cisplatin in the rat kidney

  2004cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Is concurrent chemotherapy and radiotherapy the new standard of care for locally advanced cervical cancer?

  2001cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• Development of HPLC conditions for valid determination of hydrolysis products of cisplatin.

  1999cited by this paper
• Decomposition Kinetics of Cisplatin in Human Biological Fluids

  1996cited by this paper
• Cisplatin Pharmacokinetics Using a Five‐Day Schedule During Repeated Courses of Chemotherapy in Germ Cell Tumors

  1995cited by this paper
• A sensitive postcolumn derivatization/UV detection system for HPLC determination of antitumor divalent and quadrivalent platinum complexes.

  1995cited by this paper
• Current status of chemotherapy for ovarian cancer.

  1995cited by this paper
• Determination of cisplatin and cis-diammineaquachloroplatinum(II) ion by liquid chromatography using post-column derivatization with diethyldithiocarbamate.

  1994cited by this paper
• Comparison of the pharmacokinetics of ultrafilterable cisplatin species detectable by derivatization with diethyldithiocarbamate or atomic absorption spectroscopy.

  1990cited by this paper
• The coordination chemistry of platinum anticancer drugs and related compounds with DNA

  1990cited by this paper
• Direct analysis of platinum in plasma and urine by electrothermal atomic absorption spectrophotometry.

  1989cited by this paper
• Rapid determination of platinum by flameless atomic absorption spectrophotometry following the administration of cisplatin to cancer patients.

  1986cited by this paper
• High-performance liquid chromatographic separation of platinum complexes containing the cis-1,2-diaminocyclohexane carrier ligand.

  1986cited by this paper
• A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate.

  1984cited by this paper
• Drugs five years later. Cisplatin.

  1984cited by this paper
• The reactivity of cisplatin in plasma. Implications for handling in pharmacokevetic studies

  1980cited by this paper
• Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate.

  1979cited by this paper

• Detection of Cisplatin with Boron‐Doped Diamond Thin‐Film Electrodes Using Flow Injection Analysis and Ion Exclusion Chromatography with Amperometric Detection

  2025cites this paper
• Quantification of Cisplatin Encapsulated in Nanomedicine: An Overview

  2025cites this paper
• Using HPLC for the determination of platinum drugs in biological matrixes after derivatization with diethyldithiocarbamate.

  2023cites this paper
• Label-free DNAzyme for highly sensitive detection of multiple biomolecules in real samples through target-triggered catalytic cleavage reactions with auramine O’s discriminated fluorescence emission

  2022cites this paper
• Wedelolactone protects against cisplatin-induced nephrotoxicity in mice via inhibition of organic cation transporter 2

  2021cites this paper
• Preparation, characterization and in vitro evaluation of cisplatin-bound triblock polymeric micelle solution for ovarian cancer treatment

  2021cites this paper
• Analysis of Renal Platinum Content as a Novel Approach to Protect against Cisplatin Nephrotoxicity: A Review

  2021cites this paper
• Fabrication, optimisation and evaluation of cisplatin-loaded nanostructured carriers for improved urothelium permeability for intravesical administration

  2021cites this paper
• Co-Delivery of Cisplatin and Gemcitabine via Viscous Nanoemulsion for Potential Synergistic Intravesical Chemotherapy

  2020cites this paper
• The latest advances of cisplatin liposomal formulations: essentials for preparation and analysis

  2020cites this paper
• A New Sensitive Method for Quantitative Determination of Cisplatin in Biological Samples by Kinetic Spectrophotometry

  2020cites this paper
• Dihydroartemisinin Sensitizes Esophageal Squamous Cell Carcinoma to Cisplatin by Inhibiting Sonic Hedgehog Signaling

  2020cites this paper
• Paradoxical Effect of Grape Pomace Extract on Cisplatin-Induced Acute Kidney Injury in Rats

  2019cites this paper
• Pt(IV) hybrids containing a TDO inhibitor serve as potential anticancer immunomodulators.

  2019cites this paper
• Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route

  2019cites this paper
• GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation

  2019cites this paper
• GMDTC attenuates cisplatin-induced systemic toxicity without affecting antitumor efficacy.

  2019cites this paper
• A novel and fully validated hydrophilic interaction liquid chromatography with tandem mass spectrometry method for the determination of intact carboplatin in human plasma

  2018cites this paper
• Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients

  2018cites this paper
• Characterization and in vitro evaluation of nimotuzumab conjugated with cisplatin-loaded liposomes

  2017cites this paper
• Tunable Signal-Off and Signal-On Electrochemical Cisplatin Sensor.

  2017cites this paper
• A Novel Analytical Method of Cisplatin Using the HPLC with a Naphthylethyl Group Bonded with Silica Gel (πNAP) Column.

  2017cites this paper
• Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study

  2017cites this paper
• Validation of a method to quantify platinum in cisplatin by inductively-coupled plasma

  2017cites this paper
• Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease

  2016cites this paper
• XPD c.934G>A polymorphism of nucleotide excision repair pathway in outcome of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation

  2016cites this paper
• Determination of Liposomal Cisplatin by High-Performance Liquid Chromatography and Its Application in Pharmacokinetic Studies

  2016cites this paper
• Development and Validation of an Inductively Coupled Plasma Mass Spectrometry (ICP-MS) Method for Quantitative Analysis of Platinum in Plasma, Urine, and Tissues

  2016cites this paper
• In Vitro Binding Kinetics of ChemoFilter with Cisplatin

  2016cites this paper
• Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies

  2015cites this paper
• Chitosan-Coated Fe 3 O 4 Magnetic Nanoparticles as Carrier of Cisplatin for Drug Delivery

  2015cites this paper
• Impact of drug formulation and free platinum/cisplatin ratio on hypersensitivity reactions to cisplatin: formulation matters

  2015cites this paper
• Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood–brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies

  2014cites this paper
• Decreased P‐glycoprotein is associated with the inhibitory effects of static magnetic fields and cisplatin on K562 cells

  2014cites this paper
• A phase I study of AT-101 with cisplatin and etoposide in patients with advanced solid tumors with an expanded cohort in extensive-stage small cell lung cancer

  2014cites this paper
• Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells.

  2014cites this paper
• Targeted theranostic platinum(IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ.

  2014cites this paper
• Quantitative determination of platinum derived from cisplatin in human plasma ultrafiltrate using derivatization with diethyldithiocarbamate and liquid chromatography coupled with electrospray ionization tandem mass spectrometry

  2013cites this paper
• Daintain/AIF-1 Reinforces the Resistance of Breast Cancer Cells to Cisplatin

  2012cites this paper
• Enhancement of storage stability of cisplatin-loaded protransfersome topical drug delivery system by surface modification with block copolymer and gelling agent

  2012cites this paper
• Platinum(IV) prodrugs entrapped within multiwalled carbon nanotubes: Selective release by chemical reduction and hydrophobicity reversal

  2012cites this paper
• Validated method using liquid chromatography-electrospray ionization tandem mass spectrometry for the determination of contamination of the exterior surface of vials containing platinum anticancer drugs.

  2011cites this paper
• Association of ABCC2 and CDDP-Resistance in Two Sublines Resistant to CDDP Derived from a Human Nasopharyngeal Carcinoma Cell Line

  2010cites this paper
• Evaluation of cell lysis methods for platinum metallomic studies of human malignant cells.

  2010cites this paper
• Synthesis and Characterization studies of Cisplatin/HydroxypropylβCyclodextrin Complex

  2009cites this paper
• Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.

  2009cites this paper
• Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells

  2009cites this paper
• Population pharmacokinetics of cisplatin in Asian Indian cancer patients

  2009cites this paper
• Combined VSV Oncolytic Virus and Chemotherapy for Squamous Cell Carcinoma

  2008cites this paper
• L-type fatty acid binding protein transgenic mouse as a novel tool to explore cytotoxicity to renal proximal tubules.

  2008cites this paper
• Characterization of cisplatin cytotoxicity delivered from PLGA-systems.

  2008cites this paper
• Journal of Translational Medicine Lentivirus-mediated Rnai Silencing Targeting Abcc2 Increasing the Sensitivity of a Human Nasopharyngeal Carcinoma Cell Line against Cisplatin

  2008cites this paper
• Analytical methodologies for the determination of cisplatin.

  2008cites this paper
• Hydrophilic interaction liquid chromatography (HILIC) coupled to inductively coupled plasma mass spectrometry (ICPMS) utilizing a mobile phase with a low-volatile organic modifier for the determination of cisplatin, and its monohydrolyzed metabolite

  2008cites this paper